Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cyclo Therapeutics Inc - Ordinary Shares - Class A market cap is $20.62M.
What is the 52-week high for Cyclo Therapeutics Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cyclo Therapeutics Inc - Ordinary Shares - Class A 52 week high is $1.62 as of October 07, 2025.
What is the 52-week low for Cyclo Therapeutics Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cyclo Therapeutics Inc - Ordinary Shares - Class A 52 week low is $0.55 as of October 07, 2025.
What is Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price today?
Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price today is $0.7206.
What was Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price yesterday?
Cyclo Therapeutics Inc - Ordinary Shares - Class A stock price yesterday was $0.7107.
What is the PE ratio of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cyclo Therapeutics Inc - Ordinary Shares - Class A’s P/E ratio is -0.81.
What is the Price-to-Book ratio of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cyclo Therapeutics Inc - Ordinary Shares - Class A P/B ratio is -1.5386.
What is the 50-day moving average of Cyclo Therapeutics Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cyclo Therapeutics Inc - Ordinary Shares - Class A 50-day moving average is $0.7809.
